{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:34:10Z","timestamp":1771493650501,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1124\/mol.52.5.798","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:17:40Z","timestamp":1375143460000},"page":"798-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance"],"prefix":"10.1016","volume":"52","author":[{"given":"Lan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Plunkett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.52.5.798_bib1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/annonc\/5.suppl_2.S79","article-title":"Fludarabine: present status and future developments in chronic lymphocytic leukemia and lymphoma.","volume":"5","author":"Keating","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1124\/mol.52.5.798_bib2","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/0006-2952(89)90127-5","article-title":"Interaction of arabinosyl nucleotides in K562 human leukemia cells.","volume":"38","author":"Gandhi","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1124\/mol.52.5.798_bib3","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1016\/S0021-9258(18)53162-8","article-title":"Primer RNA chain termination induced by 9-\u03b2-d-arabinofuranosyl-2-fluoroadenine 5\u2032-triphosphate: a mechanism of DNA synthesis inhibition.","volume":"268","author":"Catapano","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1124\/mol.52.5.798_bib4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0026-895X(25)08597-9","article-title":"Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.","volume":"47","author":"Yang","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.5.798_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00685844","article-title":"Fludarabine- and gemcitabine-induced apoptosis: incorporation of analog is a critical event.","volume":"36","author":"Huang","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1124\/mol.52.5.798_bib6","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1016\/S0021-9258(20)89616-1","article-title":"Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand crosslinks in Chinese hamster ovary cells.","volume":"266","author":"Jones","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1124\/mol.52.5.798_bib7","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1093\/nar\/17.12.4471","article-title":"Husain, W. Carlton, and A. Sancar. Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract.","volume":"17","author":"Sibghat-Ullah","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1124\/mol.52.5.798_bib8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1073\/pnas.70.4.1064","article-title":"Repair of DNA containing interstrand crosslinks in Escherichia coli: sequential excision and recombination.","volume":"70","author":"Cole","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.5.798_bib9","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1073\/pnas.83.21.8077","article-title":"Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position.","volume":"83","author":"Van Houten","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.5.798_bib10","first-page":"270","article-title":"Activation of programmed cell death by anticancer agents: cisplatin as a model system.","volume":"2","author":"Eastman","year":"1990","journal-title":"Cancer Cells"},{"key":"10.1124\/mol.52.5.798_bib11","series-title":"International Review of Cytology","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7696(08)62312-8","article-title":"Cell death: the significance of apoptosis","author":"Willie","year":"1980"},{"key":"10.1124\/mol.52.5.798_bib12","unstructured":"Giles, F. J., S. O\u2019Brien, H. M. Kantarjian, W. Plunkett, E. Estey, M. Beran, L.-Y. Yang, J. Seymour, L. E. Robertson, S. Lerner, and M. J. Keating. Sequential cis-platinum fludarabine, and arabinosyl cytosine (PFA) in patients with prior fludarabine therapy for chronic lymphocytic leukemia (CLL): a phase II study. Blood 88: Suppl. 1, 219b (1996)."},{"key":"10.1124\/mol.52.5.798_bib13","first-page":"4505","article-title":"Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.","volume":"51","author":"Calabretta","year":"1991","journal-title":"Cancer Res."},{"key":"10.1124\/mol.52.5.798_bib14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V86.3.1148.1148","article-title":"BCR-ABL-mediated inhibition of apoptosis with delay of G2\/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.","volume":"86","author":"Bedi","year":"1995","journal-title":"Blood"},{"key":"10.1124\/mol.52.5.798_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"10.1124\/mol.52.5.798_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0962-8924(94)90053-1","article-title":"The BCL-2 family of proteins: regulators of cell death and survival.","volume":"4","author":"Nunez","year":"1994","journal-title":"Trends Cell Biol."},{"key":"10.1124\/mol.52.5.798_bib17","first-page":"1617","article-title":"Enhanced expression of Bcl-xS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-\u03b2-d-arabinofuranosylcytosine-mediated differentiation and apoptosis.","volume":"7","author":"Ray","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1124\/mol.52.5.798_bib18","series-title":"The Metabolic Basis of Inherited Diseases","first-page":"2949","article-title":"Xeroderma pigmentosum","author":"Cleaver","year":"1989"},{"key":"10.1124\/mol.52.5.798_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0027-5107(79)90091-5","article-title":"Repair of UV-endonuclease-susceptible sites in the seven complementation groups of xeroderma pigmentosum A through G.","volume":"62","author":"Zelle","year":"1979","journal-title":"Mutat. Res."},{"key":"10.1124\/mol.52.5.798_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/carcin\/14.5.919","article-title":"Deficient gene specific repair of cisplatin-induced lesions in xeroderma pigmentosum and Fanconi\u2019s anemia cell lines.","volume":"14","author":"Zhen","year":"1993","journal-title":"Carcinogensis"},{"key":"10.1124\/mol.52.5.798_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0921-8777(90)90071-C","article-title":"Selective repair of specific chromatin domains in UV-irradiated cells from xeroderma pigmentosum complementation group C.","volume":"235","author":"Kantor","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1124\/mol.52.5.798_bib22","first-page":"4128","article-title":"Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes.","volume":"11","author":"Venema","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1124\/mol.52.5.798_bib23","first-page":"1487","article-title":"Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res."},{"key":"10.1124\/mol.52.5.798_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.2910530321","article-title":"Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum(II).","volume":"53","author":"Yang","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1124\/mol.52.5.798_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationship: the combined effects of multiple drugs or enzyme inhibitors.","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1124\/mol.52.5.798_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0003-9861(89)90119-7","article-title":"Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration.","volume":"269","author":"McConkey","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1124\/mol.52.5.798_bib27","first-page":"597","article-title":"DNA cross-linking and repair in cisplatin-resistant human cells following exposure to a new cisplatin analogue, CI-973.","volume":"5","author":"Yang","year":"1994","journal-title":"Int. J. Oncol."},{"key":"10.1124\/mol.52.5.798_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0092-8674(87)90337-0","article-title":"Processing of psoralen adducts in an active gene: repair and replication of DNA containing monoadducts and interstrand cross-links.","volume":"50","author":"Vos","year":"1987","journal-title":"Cell"},{"key":"10.1124\/mol.52.5.798_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1124\/mol.52.5.798_bib30","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1093\/nar\/17.20.8073","article-title":"Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum (II).","volume":"20","author":"Hansson","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1124\/mol.52.5.798_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0076-6879(83)01038-1","article-title":"In vitro transcription: whole cell extract.","volume":"101","author":"Manley","year":"1983","journal-title":"Methods Enzymol."},{"key":"10.1124\/mol.52.5.798_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0092-8674(92)90416-A","article-title":"Proliferating cell nuclear antigen is required for DNA excision repair.","volume":"69","author":"Shivji","year":"1992","journal-title":"Cell"},{"key":"10.1124\/mol.52.5.798_bib33","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/j.1460-2075.1991.tb04961.x","article-title":"Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA.","volume":"10","author":"Robine","year":"1991","journal-title":"EMBO J."},{"key":"10.1124\/mol.52.5.798_bib34","first-page":"69","article-title":"Biological and biochemical consequences of the human ERCC-1 repair gene after transfection into a repair-deficient CHO cell line.","volume":"183","author":"Zdziencka","year":"1987","journal-title":"Mutat. Res."},{"key":"10.1124\/mol.52.5.798_bib35","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1073\/pnas.93.13.6443","article-title":"Human MutS\u03b1 recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.","volume":"93","author":"Duckett","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.5.798_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.1566071","article-title":"Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.","volume":"256","author":"Pil","year":"1992","journal-title":"Science (Washington D. C.)"},{"key":"10.1124\/mol.52.5.798_bib37","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.89.6.2307","article-title":"Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin.","volume":"89","author":"Bruhn","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.5.798_bib38","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1073\/pnas.91.22.10394","article-title":"HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.","volume":"91","author":"Huang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.5.798_bib39","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/0006-2952(77)90275-1","article-title":"Biologic activity of 9-\u03b2-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-\u03b2-arabinofuranosyl-adenine.","volume":"26","author":"Brockman","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1124\/mol.52.5.798_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10428199309147356","article-title":"Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy.","volume":"10","author":"Gandhi","year":"1993","journal-title":"Leuk. Lymphoma"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24133871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24133871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.52.5.798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:07:21Z","timestamp":1740046041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24133871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0026895X24133871"],"URL":"https:\/\/doi.org\/10.1124\/mol.52.5.798","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.52.5.798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1997 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}